PUBLISHER: iData Research Inc. | PRODUCT CODE: 2050422
PUBLISHER: iData Research Inc. | PRODUCT CODE: 2050422
Please contact us using the inquiry form for pricing information.
The global dental bone graft substitute and other biomaterials market was valued at $2.33 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 7.2%, reaching nearly $3.8 billion by 2032.
This comprehensive report covers dental bone graft substitutes, dental barrier membranes, local antimicrobial periodontal treatments and dental wound care. Collectively, these segments are referred to as the dental biomaterials market.
The analysis includes unit sales, average selling prices (ASPs), market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
Growth in this market is closely tied to the global dental implant market. As implant adoption increases and more patients require grafting to address insufficient bone volume or quality, demand for dental bone graft substitutes and related biomaterials is expected to rise.
Market Overview
The global dental bone graft substitute and other biomaterials market includes products used to support oral tissue regeneration, implant site preparation and periodontal treatment. These products play an important role in implant dentistry and restorative dental care, especially when bone or soft tissue support is needed before or during treatment.
Dental bone graft substitutes represent a core part of the market. These products are used in socket preservation, sinus augmentation, ridge augmentation and periodontal procedures. Their demand is strongly connected to implant procedure volume because many implant candidates require grafting before placement.
Dental barrier membranes are also important in guided bone regeneration. These products help protect the graft site, support tissue separation and improve regenerative outcomes. Product innovation in resorbable and non-resorbable membranes has supported the use of advanced materials in more complex procedures.
The market also includes local antimicrobial periodontal treatments and dental soft tissue wound care products. Together, these segments support broader regenerative and surgical workflows. Growth is supported by rising implant adoption, improving dental infrastructure, better practitioner training and increasing patient expectations for functional and aesthetic outcomes.
Market Drivers
An increase in practitioner experience is a major driver of the dental biomaterials market. Dental professionals who perform bone grafting procedures are becoming more comfortable with clinical workflows and more aware of the material options available to them. This has increased confidence in treatment planning and patient communication.
As clinicians gain experience, they are more likely to use advanced and premium-priced products. Hybrid cortical-cancellous allograft mixtures, DBM putties with mineralized bone chips and titanium-reinforced barrier membranes are examples of products that may be selected for more sophisticated grafting needs. This supports both procedure quality and market value growth.
Technological improvements and greater product variety are also supporting demand. Barrier membranes have improved in handling, strength and clinical application. Titanium-reinforced membranes have expanded the possibilities for complex procedures, while newer designs and bacterial-resistant concepts help manufacturers justify higher price points and reduce pricing pressure in a competitive market.
Market Limiters
Improving dental health is a long-term limiter for the dental bone graft substitute market. In many regions, greater awareness of oral health, more frequent dental checkups and better preventive care are reducing the rate of edentulism. As future aging populations retain better dentition than previous generations, the potential pool of patients requiring extensive grafting may shrink in certain markets.
Large bone grafting procedures are another limiter. Procedures such as ridge augmentation can require 5 cc to 10 cc of grafting material, which can make treatment expensive. In some cases, the grafting procedure itself may cost more than receiving a dental implant, creating a financial barrier for patients.
Patient affordability is especially important in lower-income regions and cost-sensitive healthcare settings. Even when patients are clinically eligible for implant and grafting procedures, financial constraints may lead them to delay treatment, choose less expensive alternatives or avoid treatment altogether. This limits the conversion of clinical need into actual procedure volume.
Market Coverage and Data Scope
The report is designed to help readers evaluate how implant procedure growth, grafting needs, practitioner training, product innovation and patient affordability are shaping the global dental biomaterials market.
Markets Covered and Segmentation
Application segmentation is analyzed at a unit level only.
This market is included as part of the broader dental biomaterials report suite.
Each segment is analyzed through relevant quantitative measures, including market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
Competitive Analysis
Geistlich Pharma remained a leading competitor in the global dental bone graft substitute and dental biomaterials market in 2025. The company held significant shares in both the DBGS and dental barrier membrane segments. Its Bio-Oss(R) bovine xenograft and Bio-Gide(R) collagen membrane product lines are widely used in guided bone regeneration procedures, supporting its strong regenerative dentistry position.
Geistlich has also strengthened its market presence through strategic developments, including the 2024 acquisition of Bionnovation Biomedical, a 2025 investment in ReOss focused on patient-specific regenerative solutions and continued expansion of its regenerative portfolio. Despite rising competition from lower-priced regional xenograft and collagen membrane products, Geistlich is expected to maintain a strong position over the forecast period.
Henry Schein strengthened its position as the second-largest global competitor in the dental bone graft substitute market in 2025. Its position is driven primarily by specialty brands such as BioHorizons and ACE Southern. BioHorizons offers a broad regenerative portfolio, including MinerOss(R), Grafton(R) DBM and LADDEC(R), while ACE Southern strengthens Henry Schein's reach in surgical and grafting consumables.
ZimVie also remained a leading competitor in 2025. Its regenerative biomaterials portfolio includes allografts, xenografts, synthetic grafts and barrier membranes, supported by products such as Puros(R) Allograft, RegenerOss(R) and Endobon(R). Following its 2025 acquisition by ARCHIMED, ZimVie is expected to receive further support for investment in dental implants and regenerative biomaterials.
Technology and Practice Trends
Dental implant growth continues to shape the dental biomaterials market. Because many implant procedures require grafting to address insufficient bone volume or quality, DBGS demand is closely tied to implant procedure volume.
Premium grafting materials are gaining attention as clinician experience increases. More advanced allograft mixtures, DBM putties and specialized regenerative materials are being used in cases where clinicians seek improved handling, performance or clinical flexibility.
Barrier membrane innovation remains important. Titanium-reinforced membranes have expanded the ability to support complex guided bone regeneration procedures, while newer designs improve handling and clinical efficiency.
Non-resorbable membranes continue to evolve. Products such as ZimVie's OsseoGuard(R) non-resorbable membrane are designed to address bacterial infiltration, reflecting continued interest in products that support site protection and regenerative success.
Patient-specific regenerative solutions are emerging as a longer-term trend. Investments in customized regenerative technologies suggest that suppliers are seeking ways to improve fit, precision and clinical planning in advanced grafting procedures.
Pricing pressure remains relevant. Regional manufacturers offering lower-priced xenograft and collagen membrane products are increasing competition, especially in cost-sensitive markets. Premium brands must continue to justify higher price points through clinical evidence, product quality and practitioner trust.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
How large is the global dental bone graft substitute and other biomaterials market, and how is it expected to grow through 2032?
How are dental bone graft substitutes, barrier membranes, antimicrobial periodontal treatments and wound care products performing across global markets?
How are unit sales, average selling prices and market values changing over time?
How does growth in dental implant procedures affect demand for bone graft substitutes?
Which graft materials are gaining traction, including allografts, xenografts and synthetic options?
How are barrier membrane innovations affecting guided bone regeneration procedures?
What role do practitioner experience, product variety and premium biomaterials play in market growth?
How do improving dental health and high procedure costs limit long-term demand?
Which companies lead the dental biomaterials market, and how are Geistlich Pharma, Henry Schein and ZimVie positioned?
The Global Dental Bone Graft Substitute and Other Biomaterials Market Report from iData Research answers these questions with detailed market sizing, ASP trends, forecasts and competitive share insights. Use it to evaluate demand, benchmark leading competitors, understand technology adoption and plan for growth across the global dental biomaterials market.
List of Figures
List of Charts
executive summary
Global Dental Bone Graft Substitute and Other Biomaterials Market Overview
Competitive Analysis
Market Trends
Market Developments
Markets Included
Regions Included
Key Analysis Updates
Key Report Updates
Version History
research methodology
Global Dental Bone Graft Substitute and Other Biomaterials Market Overview
Please contact us using the inquiry form for pricing information.